Azra Avdić Salihović
WORKING HOURS
CONTACT
MD Azra Avdić Salihović works as a medical doctor at the Interventional Cardiology Department of the Medical Institute Bayer Special Hospital. She was born on January 11, 1990 in Tuzla, and after primary and secondary education, she graduated from the Faculty of Medicine in Tuzla in 2015.
The work of Azre Avdić Salihović includes work in the ward with cardiology patients, which implies taking anamnestic data from patients, monitoring recovery while correcting therapy for patients, before and after interventional cardiology procedures. It is also the part he deals with the most.
She is involved in the preparation of patients for electrophysiological study and monitoring their recovery. In addition, he also performs outpatient work, which includes surgical controls and ultrasound of the heart in consultation with senior cardiologists. He works in the cardiac surgery department as an on-call doctor, which includes cardiac surgical examinations of patients, taking anamnestic data while correcting basic laboratory findings, making decisions about therapy and postoperative treatment of patients.
Among the interventions he performs most often, the placement of urinary catheters, dressing of wounds and removal of sutures and pacemaker wires at the discharge of cardiac surgery patients stand out.
Working day Azre Avdić Salihović consists of a morning visit, and depending on which department he is in, he performs the above tasks that day. Of course, there can always be an emergency admission, most often patients with acute coronary syndrome who must be treated before entering the angio room.
Her field of interest is cardiology, outpatient work with patients using non-invasive diagnostic methods, especially cardiac ultrasound (TTE and TEE). She says that she is especially proud of her doctoral studies, which are in progress.
He actively speaks English and uses it often in his daily work.
She is happily married.
VIŠE INFORMACIJA
- WORK EXPERIENCE
- PUBLICATIONS
- MEMBERSHIPS
- PROJECTS
- VIDEO
- 2015-2017, Doctor of Medicine, Health Institution Special Hospital “Medical Institute Bayer” Tuzla.
- Ibišević M, Avdić A, Osmanović E, Kadrić N, Avdić S. Cigarette smoking among students at the University of Tuzla. Medical Archives. 2015. 69 (2); 127-129
- Sevleta A, Enes O, Nedžad K, Emir M, Merima I, Azra A. Time of occurrence and duration of atrial fibrillation following coronary artery bypass grafting. Medical Archives. 2016. 70 (2); 97-100
- Azra A, Melissa A, Amra F, Lejla M, Nadina N, Dinela P, Amir S, Alija S. MD, PhD. Burn-out syndrome in medical students studying at the Medical faculty in Tuzla and their workload during the study at the Bologna process. Proceedings from the “SaMed” student congress.
- Association of Cardiologists of Bosnia and Herzegovina
- European Society of Cardiology (ESC)
- Association of Cardiologists of Serbia
- Association for Echocardiography of Serbia
He participates as a sub-researcher in major global studies – the following are in progress:
- Odyssey outcomes study. Randomized, double-blind, placebo-controlled, comparative group study to evaluate the effect of SAR236553 / REGN727 on the occurrence of cardiovascular events in patients with recent acute coronary syndrome (Odyssey outcomes study). Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab.
- ATPCI (CL3-06790-010 study). The efficacy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention. ATPCI study An international, multicenter, randomized, double-blind, placebo-controlled study in patients treated for 2 to 4 years. – ATPCI
PAH study. Sildenafil on mortality in adults with pulmonary arterial hypertension (PAH)” - MARINER study. A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients (MARINER)
VERTIS study: randomized, double-blind, placebo-controlled, parallel-group study to assess cardiovascular outcomes following treatment with ertugliflozin (MK-8835/PF-04971729) in subjects with type 2 diabetes mellitus and established vascular disease.
GCP Training certificates:
Date of last submission: 02/23/2016 for GCP : Pfizer, Inc. online training ”Minimum Criteria for ICH E6 GCP, Good Clinical Practice for Investigational Site Staff.
